Newland Pharmaceutical Co., Ltd. Stock

Newland Pharmaceutical Co Ltd is a China-based company primarily engaged in the production, research and development, and sales of pharmaceutical intermediates, active pharmaceutical ingredients, and chemical pharmaceutical preparations. The Company mainly operates three businesses. The pharmaceutical intermediates business mainly includes the L‑p‑hydroxyphenylglycine series and p‑toluenesulfonic acid. The active pharmaceutical ingredient business primarily includes lidocaine hydrochloride, naphazoline hydrochloride, vildagliptin, lidocaine, moxifloxacin hydrochloride, esomeprazole magnesium, tadalafil, ropivacaine hydrochloride, esomeprazole sodium, etomidate, and chlorpheniramine maleate. The pharmaceutical preparations business primarily includes vildagliptin tablets, moxifloxacin hydrochloride tablets, moxifloxacin hydrochloride sodium chloride injection, and ruxolitinib phosphate tablets. The Company primarily operates in the domestic market.